An Overview of the Treatment of Less Common Non-Lactose-Fermenting Gram-Negative Bacteria.

Pharmacotherapy
Hannah K SpencerSamuel L Aitken

Abstract

Stenotrophomonas maltophilia, Burkholderia cepacia complex, Elizabethkingia spp., Chryseobacterium spp., Achromobacter spp., and Alcaligenes spp. are less-common non-lactose-fermenting bacteria that have emerged as important opportunistic pathogens. Patients at the highest risk for these infections include the immunocompromised, those with cystic fibrosis, and the critically ill. These opportunistic pathogens are frequently drug resistant through the expression of β-lactamases, multidrug efflux pumps, aminoglycoside-modifying enzymes, and target site alterations discussed in detail throughout this review. As a result, treatment is extremely challenging. For each pathogen, this review will examine the epidemiology, mechanisms of resistance, and in vitro and in vivo data including that for novel β-lactam/β-lactamase inhibitors and cefiderocol. Treatment recommendations are provided based on the available literature.

References

May 3, 1951·The New England Journal of Medicine·L WEINSTEIN, E WASSERMAN
Mar 18, 2006·Chronic Respiratory Disease·E Mahenthiralingam, P Vandamme
Apr 28, 2009·The Lancet Infectious Diseases·W John LooneyKathrin Mühlemann
Nov 6, 2009·International Journal of Antimicrobial Agents·Marisa AlmuzaraCarlos Vay
Jan 5, 2011·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yi-Tsung LinCheng-Yi Liu
Apr 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M-S HsuP-R Hsueh
Nov 3, 2011·International Journal of Pediatrics·Mehmet Ceyhan, Melda Celik
Jan 11, 2012·Clinical Microbiology Reviews·Joanna S Brooke
Jul 5, 2012·Journal of Chemotherapy·Yasemin Tezer TekçeSüha Sen
Oct 2, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Fu-Lun ChenWen-Sen Lee
May 31, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S BiswasJ-M Rolain
Aug 28, 2013·Antimicrobial Agents and Chemotherapy·J A SutcliffeT H Grossman
Aug 29, 2014·Journal of Clinical Microbiology·Genevieve McKew
Feb 24, 2015·Annals of the American Thoracic Society·Colin E Swenson, Ruxana T Sadikot
Mar 17, 2015·Expert Review of Anti-infective Therapy·Vikas GautamAmit Agarwal
May 9, 2015·Transplant Infectious Disease : an Official Journal of the Transplantation Society·L DengX Zhou
Aug 20, 2015·Medical Journal, Armed Forces India·Inam Danish KhanP Chandola
Dec 23, 2015·Emerging Infectious Diseases·Luke S P MooreAlison H Holmes
Jan 24, 2016·The Journal of Antimicrobial Chemotherapy·Elizabeth HandBryson Duhon
Sep 14, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Katherine A Rhodes, Herbert P Schweizer
Nov 5, 2016·International Journal of Antimicrobial Agents·Felicity K AbbottIan M Gould
Apr 14, 2017·Annals of the American Thoracic Society·Ranjani SomayajiValerie Waters
Aug 9, 2017·Antimicrobial Agents and Chemotherapy·Maria F MojicaRobert A Bonomo
Sep 15, 2017·The Annals of Pharmacotherapy·G Christopher WoodTimothy C Fabian
Mar 29, 2018·Antimicrobial Agents and Chemotherapy·Pranita D TammaDavid E Greenberg
Jun 16, 2018·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Rong XiaJenny Libien

❮ Previous
Next ❯

Citations

May 26, 2021·Antimicrobial Agents and Chemotherapy·Erin K McCrearyPranita D Tamma
Aug 5, 2021·Pediatric Pulmonology·Jonathan J GrantDavid C Young

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Related Papers

Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia
J A García-RodríguezGrupo Español de Estudio de Piperacilina-Tazobactam
Enfermedades infecciosas y microbiología clínica
Alba GuiuRosa Girón
© 2021 Meta ULC. All rights reserved